The Harvard Gazette reports researchers at Harvard, MIT and the Joslin Diabetes Center have successfully tested an implantable bundle containing human pancreas cells in mice and primates with type 1 diabetes.

Key to the research is alginate, a substance derived from seaweed that blocks the immune system from attacking the container for the new cells as "foreign" without the need for expensive and risky immune suppressing drugs. Read more.